Amundi Has $154.51 Million Stock Position in Humana Inc. $HUM

Amundi cut its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 14.6% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 388,972 shares of the insurance provider's stock after selling 66,413 shares during the period. Amundi owned about 0.32% of Humana worth $154,507,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. HighTower Advisors LLC raised its holdings in Humana by 12.0% in the 2nd quarter. HighTower Advisors LLC now owns 6,143 shares of the insurance provider's stock valued at $2,440,000 after buying an additional 657 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Humana during the 2nd quarter worth approximately $4,482,000. California State Teachers Retirement System grew its holdings in Humana by 39,982.9% during the 2nd quarter. California State Teachers Retirement System now owns 68,644,780 shares of the insurance provider's stock worth $27,267,080,000 after acquiring an additional 68,473,523 shares during the last quarter. Ameritas Advisory Services LLC bought a new stake in Humana during the 2nd quarter worth approximately $1,709,000. Finally, HB Wealth Management LLC increased its position in Humana by 21.8% in the 2nd quarter. HB Wealth Management LLC now owns 5,503 shares of the insurance provider's stock valued at $2,186,000 after acquiring an additional 986 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Humana Trading Up 0.4%

Shares of HUM stock opened at $403.08 on Wednesday. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a 50 day simple moving average of $388.79 and a two-hundred day simple moving average of $299.83. The company has a market cap of $48.40 billion, a P/E ratio of 38.13, a PEG ratio of 2.63 and a beta of 0.74.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to analysts' expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company's revenue for the quarter was up 26.2% compared to the same quarter last year. During the same period in the prior year, the business earned $6.27 EPS. Research analysts forecast that Humana Inc. will post 9 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana's dividend payout ratio (DPR) is presently 33.49%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on HUM shares. Zacks Research downgraded shares of Humana from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 11th. Wolfe Research reiterated an "outperform" rating and issued a $450.00 price target on shares of Humana in a research report on Monday, August 24th. Truist Financial increased their price target on Humana from $320.00 to $415.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th. UBS Group initiated coverage on Humana in a research report on Thursday, July 30th. They set a "buy" rating for the company. Finally, Robert W. Baird set a $390.00 target price on shares of Humana in a research report on Thursday, July 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $403.91.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.